AKUS Insider Trading

Insideraktier

15.482.423 shares

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Akouos Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Gennemsnitlig fortjeneste (%)	Aktier Ejet	Dele Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AKUS / Akouos Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2022-11-30	Kearny Acquisition Corp	29.992.668	12,5000	29.992.668	12,5000	374.908.350	0	13.2900	23.694.208	6,32
2020-06-30	New Enterprise Associates 16, L.P.	588.235	17,0000	588.235	17,0000	9.999.995
2020-06-30	EcoR1 Capital, LLC	1.176.000	17,0000	1.176.000	17,0000	19.992.000
2020-06-30	RA CAPITAL MANAGEMENT, LLC	825.000	17,0000	825.000	17,0000	14.025.000
2020-06-30	5AM Ventures V, L.P.	294.117	17,0000	294.117	17,0000	4.999.989
2020-06-30	Cormorant Asset Management, LLC	290.000	17,0000	290.000	17,0000	4.930.000
2020-06-30	Novartis Bioventures Ltd	125.000	17,0000	125.000	17,0000	2.125.000
2020-06-30	Preston Heather	5.882	17,0000	5.882	17,0000	99.994
2020-06-30	Sofinnova Venture Partners X, L.P.	58.823	17,0000	58.823	17,0000	999.991
2020-06-30	Pivotal bioVenture Partners Fund I, L.P.	294.117	17,0000	294.117	17,0000	4.999.989

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AKUS / Akouos Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2020-12-29	5AM Ventures V, L.P.	111.648	18,0000	111.648	18,0000	2.009.664	342	7.6500	-1.155.557	-57,50
2020-12-29	5AM Ventures V, L.P.	358.352	18,0000	358.352	18,0000	6.450.336

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2022-12-02	2022-11-30	4	Makhzoumi Mohamad See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	McKenna Michael John	AKUS	Common Stock	U - Other	D			-82.385			0
2022-12-02	2022-11-30	4	New Enterprise Associates 16, L.P.	AKUS	Common Stock	U - Other	D			-4.294.207			0
2022-12-02	2022-11-30	4	PARMAR KUSH	AKUS	Common Stock	U - Other	I			-982.453			0
2022-12-02	2022-11-30	4	PARMAR KUSH	AKUS	Common Stock	U - Other	I			-3.153.333			0
2022-12-02	2022-11-30	4	TZIANABOS ARTHUR	AKUS	Common Stock	U - Other	D			-26.930			0
2022-12-02	2022-11-30	4	Behbahani Ali See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	SANDELL SCOTT D See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	Florence Anthony A. Jr. See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	BASKETT FOREST See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	Preston Heather	AKUS	Common Stock	U - Other	D			-5.882			0
2022-12-02	2022-11-30	4	Walker Paul Edward See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	Sonsini Peter W. See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	Chang Carmen See Note 3	AKUS	Common Stock	U - Other	I			-4.294.207			0
2022-12-02	2022-11-30	4	Simons Emmanuel	AKUS	Common Stock	U - Other	D			-272.582			0
2022-12-02	2022-11-30	4	Wellman Jennifer Anne	AKUS	Common Stock	U - Other	D			-12.338			0
2022-12-02	2022-11-30	4	5AM Ventures V, L.P. 5AM Opportunities I, L.P.	AKUS	Common Stock	U - Other	I			-982.453			0
2022-12-02	2022-11-30	4	5AM Ventures V, L.P. By 5AM Ventures V, L.P.	AKUS	Common Stock	U - Other	I			-3.153.333			0
2022-12-01	2022-11-30	4	Kearny Acquisition Corp	AKUS	Common Stock	P - Purchase	D		12,5000	29.992.668	374.908		100
2022-02-17	2022-02-15	4	McKenna Michael John	AKUS	Stock Option (right to buy)	A - Award	D	5,89		90.000		90.000
2022-02-17	2022-02-15	4	Minegishi Sachiyo	AKUS	Stock Option (right to buy)	A - Award	D	5,89		150.000		150.000
2022-02-17	2022-02-15	4	Simons Emmanuel	AKUS	Stock Option (right to buy)	A - Award	D	5,89		380.000		380.000
2022-02-17	2022-02-15	4	Wellman Jennifer Anne	AKUS	Stock Option (right to buy)	A - Award	D	5,89		130.000		130.000
2021-06-25	2021-06-24	4	Mathers Edward T	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-06-25	2021-06-24	4	Preston Heather	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-06-25	2021-06-24	4	PARMAR KUSH	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-06-25	2021-06-24	4	Ramasastry Saira	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-06-25	2021-06-24	4	Smith Christopher M	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-06-25	2021-06-24	4	SATO VICKI L	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-06-25	2021-06-24	4	TZIANABOS ARTHUR	AKUS	Stock Option (right to buy)	A - Award	D	13,39		16.000		16.000
2021-02-17	2021-02-15	4	Minegishi Sachiyo	AKUS	Stock Option (right to buy)	A - Award	D	17,97		15.000		15.000
2021-02-17	2021-02-15	4	Wellman Jennifer Anne	AKUS	Stock Option (right to buy)	A - Award	D	17,97		100.000		100.000
2021-02-17	2021-02-15	4	McKenna Michael John	AKUS	Stock Option (right to buy)	A - Award	D	17,97		70.000		70.000
2021-02-17	2021-02-15	4	Robinson Gregory Scott	AKUS	Stock Option (right to buy)	A - Award	D	17,97		60.000		60.000
2021-02-17	2021-02-15	4	Simons Emmanuel	AKUS	Stock Option (right to buy)	A - Award	D	17,97		250.000		250.000
2020-12-31	2020-12-29	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	S - Sale	I		18,0000	-111.648	-2.010		982.453
2020-12-31	2020-12-29	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	S - Sale	I		18,0000	-358.352	-6.450		3.153.331
2020-12-31	2020-12-29	4	5AM Ventures V, L.P. Footnote	AKUS	Common Stock	S - Sale	I		18,0000	-111.648	-2.010		982.453
2020-12-31	2020-12-29	4	5AM Ventures V, L.P. Footnote	AKUS	Common Stock	S - Sale	I		18,0000	-358.352	-6.450		3.153.331
2020-10-15	2020-10-01	4	Wellman Jennifer Anne	AKUS	Stock Option (right to buy)	A - Award	D	22,45		100.000		100.000
2020-10-15	2020-10-01	4	Minegishi Sachiyo	AKUS	Stock Option (right to buy)	A - Award	D	22,45		257.780		257.780
2020-10-15		3	Wellman Jennifer Anne	AKUS	Common Stock		D						12.338
2020-10-05	2020-10-01	4	Robinson Gregory Scott	AKUS	Stock Option (right to buy)	A - Award	D	22,45		30.000		30.000
2020-10-05	2020-10-01	4	McKenna Michael John	AKUS	Stock Option (right to buy)	A - Award	D	22,45		100.000		100.000
2020-07-22	2020-06-26	4/A	Simons Emmanuel	AKUS	Stock Option (right to buy)	A - Award	D	17,00		145.095		145.095
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Series B Preferred Stock	C - Conversion	I			-16.858.076		0
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Series B Preferred Stock	C - Conversion	I			-21.072.595		0
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Series A Preferred Stock	C - Conversion	I			-42.102.730		0
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Series Seed Preferred Stock	C - Conversion	I			-10.826.417		0
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Common Stock	P - Purchase	I		17,0000	294.117	5.000		1.094.101
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Common Stock	C - Conversion	I			799.984			799.984
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Common Stock	C - Conversion	I			999.980			3.511.683
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Common Stock	C - Conversion	I			1.997.946			2.511.703
2020-07-02	2020-06-30	4	5AM Ventures V, L.P. footnote	AKUS	Common Stock	C - Conversion	I			513.757			513.757
2020-07-02	2020-06-30	4	EcoR1 Capital, LLC See Notes 2 and 3	AKUS	Series B Convertible Preferred Stock	C - Conversion	I			-16.858.076		0
2020-07-02	2020-06-30	4	EcoR1 Capital, LLC See Notes 2 and 3	AKUS	Common Stock	P - Purchase	I		17,0000	1.176.000	19.992		1.975.984
2020-07-02	2020-06-30	4	EcoR1 Capital, LLC See Notes 2 and 3	AKUS	Common Stock	C - Conversion	I			799.984			799.984
2020-07-02	2020-06-30	4	RA CAPITAL MANAGEMENT, LLC	AKUS	Series B Preferred Stock	C - Conversion	I			-12.643.557		0
2020-07-02	2020-06-30	4	RA CAPITAL MANAGEMENT, LLC	AKUS	Series A Preferred Stock	C - Conversion	I			-18.044.028		0
2020-07-02	2020-06-30	4	RA CAPITAL MANAGEMENT, LLC	AKUS	Common Stock	P - Purchase	I		17,0000	825.000	14.025		2.281.249
2020-07-02	2020-06-30	4	RA CAPITAL MANAGEMENT, LLC	AKUS	Common Stock	C - Conversion	I			599.987			1.456.249
2020-07-02	2020-06-30	4	RA CAPITAL MANAGEMENT, LLC	AKUS	Common Stock	C - Conversion	I			856.262			856.262
2020-07-02	2020-06-30	4	Partners Innovation Fund, LLC	AKUS	Series B Preferred Stock	C - Conversion	D			-119.997		0
2020-07-02	2020-06-30	4	Partners Innovation Fund, LLC	AKUS	Series A Preferred Stock	C - Conversion	D			-342.505		0
2020-07-02	2020-06-30	4	Partners Innovation Fund, LLC	AKUS	Series Seed Preferred Stock	C - Conversion	D			-102.751		0
2020-07-02	2020-06-30	4	Partners Innovation Fund, LLC	AKUS	Common Stock	C - Conversion	D			119.997			565.253
2020-07-02	2020-06-30	4	Partners Innovation Fund, LLC	AKUS	Common Stock	C - Conversion	D			342.505			445.256
2020-07-02	2020-06-30	4	Partners Innovation Fund, LLC	AKUS	Common Stock	C - Conversion	D			102.751			102.751
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Series B Preferred Stock	C - Conversion	I			-16.858.076		0
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Series B Preferred Stock	C - Conversion	I			-21.072.595		0
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Series A Preferred Stock	C - Conversion	I			-42.102.730		0
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Series Seed Preferred Stock	C - Conversion	I			-10.826.417		0
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	P - Purchase	I		17,0000	294.117	5.000		1.094.101
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	C - Conversion	I			799.984			799.984
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	C - Conversion	I			999.980			3.511.683
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	C - Conversion	I			1.997.946			2.511.703
2020-07-02	2020-06-30	4	PARMAR KUSH See Footnotes	AKUS	Common Stock	C - Conversion	I			513.757			513.757
2020-07-02	2020-06-30	4	Novartis Bioventures Ltd	AKUS	Series B Preferred Stock	C - Conversion	I			-199.996		0
2020-07-02	2020-06-30	4	Novartis Bioventures Ltd	AKUS	Series A Preferred Stock	C - Conversion	I			-856.262		0
2020-07-02	2020-06-30	4	Novartis Bioventures Ltd	AKUS	Common Stock	P - Purchase	I		17,0000	125.000	2.125		1.181.258
2020-07-02	2020-06-30	4	Novartis Bioventures Ltd	AKUS	Common Stock	C - Conversion	I			199.996			1.056.258
2020-07-02	2020-06-30	4	Novartis Bioventures Ltd	AKUS	Common Stock	C - Conversion	I			856.262			856.262
2020-07-02	2020-06-30	4	Preston Heather	AKUS	Series B Preferred Stock	C - Conversion	I			-1.499.971		0
2020-07-02	2020-06-30	4	Preston Heather	AKUS	Common Stock	P - Purchase	D		17,0000	5.882	100		5.882
2020-07-02	2020-06-30	4	Preston Heather	AKUS	Common Stock	P - Purchase	I		17,0000	294.117	5.000		1.794.088
2020-07-02	2020-06-30	4	Preston Heather	AKUS	Common Stock	C - Conversion	I			1.499.971			1.499.971
2020-07-02	2020-06-30	4	Partners Innovation Fund II, L.P.	AKUS	Series B Preferred Stock	C - Conversion	D			-79.998		0
2020-07-02	2020-06-30	4	Partners Innovation Fund II, L.P.	AKUS	Series A Preferred Stock	C - Conversion	D			-228.336		0
2020-07-02	2020-06-30	4	Partners Innovation Fund II, L.P.	AKUS	Series Seed Preferred Stock	C - Conversion	D			-68.501		0
2020-07-02	2020-06-30	4	Partners Innovation Fund II, L.P.	AKUS	Common Stock	C - Conversion	D			79.998			376.835
2020-07-02	2020-06-30	4	Partners Innovation Fund II, L.P.	AKUS	Common Stock	C - Conversion	D			228.336			296.837
2020-07-02	2020-06-30	4	Partners Innovation Fund II, L.P.	AKUS	Common Stock	C - Conversion	D			68.501			68.501
2020-07-02	2020-06-30	4	Cormorant Asset Management, LLC See Footnotes	AKUS	Series B Convertible Preferred Stock	C - Conversion	I			499.989		0
2020-07-02	2020-06-30	4	Cormorant Asset Management, LLC See Footnotes	AKUS	Common Stock	P - Purchase	I		17,0000	290.000	4.930		789.989
2020-07-02	2020-06-30	4	Cormorant Asset Management, LLC See Footnotes	AKUS	Common Stock	C - Conversion	I			499.989			499.989
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Series B Preferred Stock	C - Conversion	D			-1.199.976		0
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Series A Preferred Stock	C - Conversion	D			-1.992.238		0
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Series Seed Preferred Stock	C - Conversion	D			-513.758		0
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Common Stock	P - Purchase	D		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Common Stock	C - Conversion	D			1.199.976			3.705.972
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Common Stock	C - Conversion	D			1.992.238			2.505.996
2020-07-01	2020-06-30	4	New Enterprise Associates 16, L.P.	AKUS	Common Stock	C - Conversion	D			513.758			513.758
2020-07-01	2020-06-30	4	Sofinnova Venture Partners X, L.P.	AKUS	Series B Preferred Stock	C - Conversion	D			-12.643.557		0
2020-07-01	2020-06-30	4	Sofinnova Venture Partners X, L.P.	AKUS	Series A Preferred Stock	C - Conversion	D			-18.044.028		0
2020-07-01	2020-06-30	4	Sofinnova Venture Partners X, L.P.	AKUS	Common Stock	P - Purchase	D		17,0000	58.823	1.000		1.515.073
2020-07-01	2020-06-30	4	Sofinnova Venture Partners X, L.P.	AKUS	Common Stock	C - Conversion	D			599.988			1.456.250
2020-07-01	2020-06-30	4	Sofinnova Venture Partners X, L.P.	AKUS	Common Stock	C - Conversion	D			856.262			856.262
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	Sonsini Peter W. See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	Marshfield Advisers LLC	AKUS	Series B Preferred Stock	C - Conversion	D			149.997		0
2020-07-01	2020-06-30	4	Marshfield Advisers LLC	AKUS	Common Stock	C - Conversion	D			149.997			149.997
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	Behbahani Ali See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	Walker Paul Edward See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	Makhzoumi Mohamad See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	MAKOWER JOSHUA See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	SANDELL SCOTT D See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	BASKETT FOREST See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	Chang Carmen See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Series B Preferred Stock	C - Conversion	I			-1.199.976		0
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Series A Preferred Stock	C - Conversion	I			-1.992.238		0
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Series Seed Preferred Stock	C - Conversion	I			-513.758		0
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Common Stock	P - Purchase	I		17,0000	588.235	10.000		4.294.207
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Common Stock	C - Conversion	I			1.199.976			3.705.972
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Common Stock	C - Conversion	I			1.992.238			2.505.996
2020-07-01	2020-06-30	4	Florence Anthony A. Jr. See Note 2	AKUS	Common Stock	C - Conversion	I			513.758			513.758
2020-07-01	2020-06-30	4	Pivotal bioVenture Partners Fund I, L.P.	AKUS	Series B Preferred Stock	C - Conversion	I			-1.499.971		0
2020-07-01	2020-06-30	4	Pivotal bioVenture Partners Fund I, L.P.	AKUS	Common Stock	P - Purchase	I		17,0000	294.117	5.000		1.794.088
2020-07-01	2020-06-30	4	Pivotal bioVenture Partners Fund I, L.P.	AKUS	Common Stock	C - Conversion	I			1.499.971			1.499.971
2020-06-30	2020-06-26	4	Ramasastry Saira	AKUS	Stock Option (right to buy)	A - Award	D	17,00		22.625		22.625
2020-06-30	2020-06-30	4	Simons Emmanuel	AKUS	Series Seed-1 Preferred Stock	C - Conversion	D			-35.312		0
2020-06-30	2020-06-26	4	Simons Emmanuel	AKUS	Stock Option (right to buy)	A - Award	D	17,00		838.066		838.066
2020-06-30	2020-06-26	4	Simons Emmanuel	AKUS	Common Stock	C - Conversion	D			35.312			35.312
2020-06-29		3	Lonza Houston, Inc.	AKUS	Common Stock		D						237.270
2020-06-25		3	McKenna Michael John	AKUS	Common Stock		D						164.770
2020-06-25		3	McKenna Michael John	AKUS	Common Stock		D						164.770
2020-06-25		3	McKenna Michael John	AKUS	Common Stock		D						164.770
2020-06-25		3	Simons Emmanuel	AKUS	Common Stock		D						474.540
2020-06-25		3	Simons Emmanuel	AKUS	Common Stock		D						474.540
2020-06-25		3	Simons Emmanuel	AKUS	Common Stock		D						474.540
2020-06-25		3	Massachusetts Eye & Ear Infirmary	AKUS	Common Stock		D						237.270
2020-06-25		3	Massachusetts Eye & Ear Infirmary	AKUS	Common Stock		D						237.270
2020-06-25		3	Massachusetts Eye & Ear Infirmary	AKUS	Common Stock		D						237.270
2020-06-25		3	Robinson Gregory Scott	AKUS	Common Stock		D						50.300
2020-06-25		3	Robinson Gregory Scott	AKUS	Common Stock		D						50.300
2020-06-25		3	Robinson Gregory Scott	AKUS	Common Stock		D						50.300
2020-06-25		3	Smith Christopher M	AKUS	Common Stock		D						33.550
2020-06-25		3	Smith Christopher M	AKUS	Common Stock		D						33.550
2020-06-25		3	Smith Christopher M	AKUS	Common Stock		D						33.550
2020-06-25		3	TZIANABOS ARTHUR	AKUS	Common Stock		D						53.860
2020-06-25		3	TZIANABOS ARTHUR	AKUS	Common Stock		D						53.860
2020-06-25		3	TZIANABOS ARTHUR	AKUS	Common Stock		D						53.860

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

AKUS / Akouos Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5